Clinical Trial Update: Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/Phase 3 trial is evaluating the biological and clinical effects of Acetyl-L-carnitine in amyotrophic lateral sclerosis and is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: RECRUITING